Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid in capital	Accumulated deficit	Accumulated other comprehensive income
Beginning balance (in shares) at Dec. 31, 2022		141,590
Beginning balance at Dec. 31, 2022	$ 227,335	$ 0	$ 226,327	$ (38,443)	$ 39,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	917		917
Stock issued under stock incentive plans, net (in shares)		158
Stock issued under stock incentive plans, net	(150)		(150)
Repurchase of common stock (in shares)		(13)
Repurchase of common stock	(195)		(195)
Dividends declared	(262,213)			(262,213)
Comprehensive income (loss)	(14,108)			(10,195)	(3,913)
Ending balance (in shares) at Apr. 01, 2023		141,735
Ending balance at Apr. 01, 2023	$ (48,414)	$ 0	226,899	(310,851)	35,538
Beginning balance (in shares) at Dec. 30, 2023	160,453	160,453
Beginning balance at Dec. 30, 2023	$ 376,055	$ 0	593,109	(247,541)	30,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	19,129		19,129
Stock issued under stock incentive plans, net (in shares)		1,275
Stock issued under stock incentive plans, net	2,958		2,958
Comprehensive income (loss)	$ (3,185)			(467)	(2,718)
Ending balance (in shares) at Mar. 30, 2024	161,728	161,728
Ending balance at Mar. 30, 2024	$ 394,957	$ 0	$ 615,196	$ (248,008)	$ 27,769